PIK3CA and neoplasm: It has been found that inhibiting the PI3K/AKT/mTOR pathway induces apoptosis in cSCC cells, inhibits tumor cell proliferation (Ghafouri-Fard et al., 2022[71]), and decreases tumor angiogenesis (new blood vessel formation to promote tumor growth) (Perrotte et al., 1999[139]).